. 2014 Aug 4;4(2):12. doi: 10.7603/s40681-014-0012-3

Table 3.

Results of AST, ALT , plasma lipids and lipid peroxidation before and after the AP supplementation

	N	HFD	RN	1×AP	2×AP
AST (U/L)
Week 8	68.0 ± 3.6^b	133.8 ± 16.6^a	126.8 ± 23.8^a	133.8 ± 8.0^a	124.5 ± 19.1^a
Week 12	71.1 ± 1.2^b	113.0 ± 19.1^a	87.3 ± 8.0^ab	80.1 ± 6.2^b	79.2 ± 4.4^b
ALT (U/L)
Week 8	37.3 ± 0.9^b	57.7 ± 4.2^a	52.7 ± 2.8^a	65.5 ± 7.8^a	62.2 ± 3.8^a
Week 12	31.4 ± 1.4^b	92.9 ± 26.0^a	45.8 ± 3.3^ab	47.3 ± 5.2^ab	41.6 ± 5.1^b
Triglyceride (mg/dL)
Week 8	37.3 ± 1.2^b	57.8 ± 5.3^a	51.5 ± 3.0^a	50.8 ± 2.9^a	54.2 ± 3.8^a
Week 12	21.0 ± 2.3^b	40.9 ± 2.8^a	38.1 ± 2.8^a	27.6 ± 4.3^b	23.1 ± 1.4^b
TC (mg/dL)
Week 8	46.7 ± 2.0^b	69.1 ± 6.9^a	64.2 ± 2.8^a	69.8 ± 5.0^a	69.0 ± 2.9^a
Week 12	46.3 ± 3.9^c	76.7 ± 2.9^a	58.4 ± 3.3^b	49.4 ± 2.4^bc	48.4 ± 3.9^bc
VLDL-C (mg/dL)
Week 8	26.7 ± 1.5^b	47.8± 5.6^a	43.0 ± 3.0^a	46.2 ± 6.0^a	45.7 ± 4.4^b
Week 12	16.8 ± 2.5^c	29.3 ± 2.7^a	24.6 ± 1.6^ab	22.8 ± 1.7^bc	20.1 ± 1.6^bc
LDL-C (mg/dL)
Week 8	5.3 ± 0.6^b	23.2 ± 4.8^a	22.3 ± 3.2^a	18.5 ± 3.3^a	24.5 ± 4.4^a
Week 12	16.1 ± 0.6^c	38.0 ± 3.2^a	23.6 ± 2.5_b	18.4 ± 1.4^bc	18.4 ± 1.4^bc
HDL-C (mg/dL)
Week 8	14.2 ± 0.7^a	6.0 ± 1.1^b	7.0 ± 1.0^b	7.8 ± 0.8^b	7.2 ± 1.4^b
Week 12	13.0 ± 1.0^a	5.2 ± 0.8^c	8.3 ± 0.8^b	13.2 ± 1.3^a	13.2 ± 1.3^a
FFA (nmol/μL)
Week 8	0.36 ± 0.02^b	0.66 ± 0.11^a	0.58 ± 0.05^a	0.60 ± 0.23^a	0.59 ± 0.08^a
Week 12	0.32 ± 0.07^b	0.56 ± 0.18^a	0.48 ± 0.12^ab	0.36 ± 0.13^b	0.32 ± 0.06^b
MDA (μM)
Week 8	14.9 ± 1.5^b	21.5 ± 0.6^a	20.6 ± 0.9^a	21.1 ± 0.9^a	20.8 ± 0.9^a
Week 12	17.0 ± 0.9^b	22.6 ± 1.4^a	19.7 ± 0.5^ab	19.5 ± 1.6^ab	16.8 ± 2.7^b

Data presented as mean ± SEM.Superscripts represent statistically significant differences among groups. p <0.05 N: normal dietary group, HFD: high fat diet group, RN: normal diet revert group, 1×AP, and 2×AP: normal diet recovery supplemented with 0.75%(w/w) and 1.5% (w/w) AP.